The Cancer Prognostics and Health Outcomes Unit of the University of Montreal, directed by Dr. Pierre Karakiewicz, in collaboration with several centers of excellence from around the world has developed a series of computerized devices to help patients and their physicians decide among the major treatment choices for several cancers and non-malignant conditions. The available applications, developed by Pierre Karakiewicz et al., can be used in prostate, bladder, kidney, adrenal, upper track urinary and penile cancers, as well as in renal transplantation.